Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of different doses of sufentanil on the median effective concentration of remimazolam during gastroenteroscopy in patients with cirrhosis
ChiCTR2100050674Phase 4Recruiting
- Sponsor
- The Third Hospital of Hebei Medical University
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Cirrhosis (4 arms), sponsored by The Third Hospital of Hebei Medical University. Primary endpoint: Body response (movement during procedure). Started Oct 2021; status: recruiting.
02
Drugs
remimazolam
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on ChiCTR2100050674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050674.